Built Here. Built to Last.
Your Wednesday VC Breakfast Rundown
Today’s companies aren’t just tech stories, they’re American stories. Because “Made in the USA” isn’t just a label. It’s a mindset. It’s about building with intention, with grit, with pride in where you come from and who you’re building for. And in today’s rundown, every founder brings that spirit to the surface.
These aren’t companies chasing scale at all costs. They’re choosing to create impact close to home. Hiring here. Manufacturing here. Innovating in a way that’s tied to place and people. They understand that building something great doesn’t mean building it far away. It means building it right, with care, with standards, with community in mind.
What makes this group stand out isn’t just their tech. It’s their commitment to doing things the hard way when it’s the right way. That’s not nostalgia. That’s discipline. That’s the kind of foundation that doesn’t shake when the winds change.
Made here. Maintained here. And built for more than just exit.
This is what American resilience looks like, one startup at a time.
CRED raised $15M (defy.vc, HOF Capital, LDV Partners) to weaponize predictive intelligence. Jon Carr-Harris and his team built a platform that fuses internal ops data with market signals to forecast revenue before it happens. 25 enterprise clients already pulled in $100M+ in net new revenue. If AI is the future, CRED is its profit engine.
North.cloud snagged $5M Series A (Companyon Ventures) to slash cloud computing waste with real-time automation. Matt Biringer and Yassine Açoine turned a 40-day MVP into a $6M ARR machine that cuts @AWS and @GCP bills by 55%. Their Arctic and Agent North tools are a FinOps masterclass. Engineers don’t just like it, they depend on it.
Campfire lit up a $35M Series A (Accel, Foundation Capital, Capital 49) to torch legacy ERP. John Glasgow built a fast, AI-native platform already replacing NetSuite and QuickBooks at over 100 companies. Their finance OS reduces close times from 15 days to 3. With 10x revenue in 10 months, they’re not iterating, they’re dominating.
Civ Robotics raised $7.5M Series A (AlleyCorp, Bobcat Company, Trimble Ventures) to bring automation to construction tech layout. Tom Yeshurun and Liav Muler turned $5M of layout pain into CivDot, robotics that mark 3,000 points/day with sub-inch precision. Already profitable with 100+ units in the field. They’re paving infrastructure’s future, point by point.
Halogen Ventures just closed Fund III at $30M to double down on the $7.5T “Future of Family” category. Jesse Draper and her team are reshaping venture capital with a mandate that’s bold and overdue: bet on companies where at least one founder is a woman. Backers like Innovate Alabama and GingerBread Capital are turning this fund into a national force for consumer tech and B2B software. 70+ companies, $10B+ in value, and they’re just getting warmed up.
Gallant raised $18M Series B (Digitalis Ventures, BOLD Capital Partners, NovaQuest Capital Management) to bring allogeneic stem cell therapies to veterinary care. Dr. Linda Black, DVM, PhD is delivering off-the-shelf MSCs with science that heals, not just manages. First FDA-labeled therapy expected in 2026. Gallant’s not treating symptoms, they’re rewriting the pet health standard.
Wisq extended its Series A with $15M (Norwest, Shasta Ventures, True Ventures) to transform HR from ticket chaos to AI clarity. Jim Barnett, Goutham Kurra, and Chih-Po Wen built Harper AI, a generalist that outperforms and outscales. 94% accuracy on SHRM exams, 80% less HR workload. This isn’t automation, it’s HR’s second brain.
Emerald AI secured $24.5M seed (Radical Ventures, nVentures) to align AI workloads with energy grid demand. Dr. Varun Sivaram built Conductor, a platform that orchestrates compute like a symphony across utility constraints. Proven in Phoenix with Oracle and EPRI, already cutting GPU load 25%. If AI is the race, Emerald is building the track with infrastructure intelligence.
RECOGNIZE closed its second fund at $1.7B in under five months, led by Francisco D'Souza, Charles Phillips, and David Wasserman. Their focus? Transforming the $2T digital services industry with surgical capital and unmatched operational depth. From SDG to AST, their exits speak louder than pitch decks. This isn’t private equity, they’re building blueprints for repeatable scale.
Syntis Bio pulled in $38M (Cerberus Ventures GmbH, NIH grants) to revolutionize drug delivery through polymer-coated gut tech. Rahul Dhanda, with Massachusetts Institute of Technology legends Robert Langer and Giovanni Traverso, is crafting oral obesity and enzyme therapies that bypass injections entirely. SYNT-101 mimics surgery without the scalpel. With INDs lined up, they’re not chasing markets, they’re building them for biotech and metabolic health.
Field Medical closed a $35M Series B (BioStar Capital, CUE Growth Partners) to reset how we treat ventricular tachycardia. Dr. Steven Mickelsen, inventor of pulsed field ablation, is back with FieldForce, a device designed for deep, precise cardiac lesions. Already FDA Breakthrough designated. This isn’t a medtech upgrade, it’s a new heartbeat for cardiac care.
Deeto raised $12.5M Series A (Jump Capital) to turn customer voice into sales velocity. Eran Baron, Golan Raz, and Yossi Gelman built a platform that turns client feedback into references, reviews, and revenue. Atlassian and Dropbox are already in. In the $1.6B advocacy market, Deeto’s the new trust layer for B2B growth.
Let’s connect and keep the momentum going across the tech ecosystem. Whether you’re a founder shaping the future, a leader driving change, a VC backing bold ideas, or an investor spotting the next big thing—together, we’re pushing boundaries. Proud to be building the future with you.
Let’s connect on LinkedIn and Twitter (X), and keep the conversation going.
Full rundowns live www.devcuration.com
If engineering peace of mind is what you crave, Vention is your zen.